Viewing Study NCT07031700


Ignite Creation Date: 2025-12-26 @ 12:15 PM
Ignite Modification Date: 2026-01-01 @ 12:56 AM
Study NCT ID: NCT07031700
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-22
First Post: 2025-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module